期刊文献+

枳实对高脂血症患者血脂和内皮功能的影响 被引量:15

The Influence of Fructus Aurantii Immaturus on Blood Lipids and Vascular Endothelial Function in Patients with Hyperlipidemia
下载PDF
导出
摘要 目的探讨枳实对高脂血症患者血脂及内皮功能的影响。方法 80例高脂血症患者随机分成枳实组、常规组。所有患者分别于入选第2日、用药8周末取空腹静脉血,行血三酰甘油(TG)、胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、一氧化氮(NO)、内皮素(ET-1)测定。另选本院同期健康体检40名作为正常对照组,要求采血前两周未服用任何药物。结果高脂血症患者血NO水平显著低于正常组,ET-1水平明显高于正常组(P<0.01)。治疗8周末两病例组血HDL-C、NO水平显著升高、TG、TC、LDL-C、ET-1水平明显降低,枳实组效果显著优于常规组(P<0.01),但两组的NO、ET-1水平与正常组仍有明显差别(P<0.01)。结论枳实能够改善高脂血症患者血脂含量及内皮功能。 Objective To explore the effect of fructus aurantii immaturus on blood lipids level and vascular endothelial function in patients(pts) with hyperlipidemia.Methods Eighty pts with hyperlipidemia were divided randomly into control group(n=40) treated by routine therapy and treatment group(n=40) treated by fructus aurantii immaturus for 8 weeks.The total cholesterol(TC),triglycerides(TG),high-density lipoprotein cholestrol(HDL-C),low-density lipoprotein cholesterol(LDL-C),nitric oxide(NO) and endothelin(ET-1) were tested before and after treatment.Forty healthy people were selected as normal control group.Results The level of NO was lower and ET-1 content was higher in pts with hyperlipidemia compared with that in normal control group(P0.01).The serum levels of HDL-C,NO obviously increased and the blood levels of ET-1,TC,TG,and LDL-C were decreased in both groups after treatment(P0.01),and there was difference between the two groups(P0.01).Conclusion Fructus aurantii immaturus can adjust the abnormal blood lipids and improve the endothelial function in pts with hyperlipidemia.
出处 《中西医结合心脑血管病杂志》 2012年第3期283-285,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 枳实 高脂血症 内皮功能 fructus aurantii immaturus hyperlipidemia endothelial function
  • 相关文献

参考文献16

  • 1Jacobson TA.The safety of aggressive statin therapy:How muchcan low-density lipoprotein cholesterol be lowered[J].Mayo ClinProc,2006,81(9):1225-1231.
  • 2Duffy D,Rader DJ.High-density lipoprotein cholesterol therapies:The next frontier in lipid management[J].J Cardiopulm Rehabil,2006,26(1):1-8.
  • 3Duvall WL.Endothelial dysfunction and antioxidants[J].Mt SinaiJ Med,2005,72(2):71-80.
  • 4吉中强,高晓昕,宋鲁卿,纪文岩,王培霞,刘宗田,牛其昌,刘孟宇.调脂中药抗血小板聚集和对红细胞流变性影响的实验研究[J].中医药研究,1999,15(5):47-49. 被引量:17
  • 5吉中强,宋鲁卿,高晓昕,刘宗田,牛其昌,刘孟宇.11种中药对大鼠血小板聚集和红细胞流变性的影响[J].山东中医杂志,2000,19(2):107-108. 被引量:34
  • 6吉中强,宋鲁卿,牛其昌.15种理气中药体外对人血小板聚集的影响[J].中草药,2001,32(5):428-430. 被引量:50
  • 7方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 8Tesfamariam B.The effects of HMG-CoA reductase inhibitors onendothelial function[J].Am J Cardiovasc Drugs,2006,6(2):115-120.
  • 9Moroi M,Zhang L,Yasuda T,et al.Interaction of genetic deficien-cy of endothelial nitric oxide,gender,and pregnancy in vascular re-sponse to injury in mice[J].J Clin Invest,1998,101:1225-1232.
  • 10Fleming I,Busse RNO:The primary EDRF[J].J Mol Cell Cardi-ol,1999,31:5-14.

二级参考文献25

共引文献3234

同被引文献280

引证文献15

二级引证文献167

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部